Hepatitis B virus (HBV) and hepatitis C virus (HCV) cause 1.3 million deaths annually. To
prevent more than 7 million deaths by 2030, the World Health Organization set goals to …

Abstract The Infectious Diseases Society of America and the American Association for the
Study of Liver Diseases have collaboratively developed evidence-based guidance …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

Importance Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in
the US and a leading cause of complications from chronic liver disease. HCV is associated …

Importance Infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality
in the United States, and incidence has increased rapidly in recent years, likely owing to …

Background & Aims Most persons infected with hepatitis C virus (HCV) in the United States
were born from 1945 through 1965; testing is recommended for this cohort. However, HCV …

Abstract Background Hepatitis C virus'(HCV) chronic prevalence among pregnant women in
the United States doubled nationally from 2009–2014 (~ 0.7%), yet many cases remain …

Background & Aims In Europe, hepatitis C virus (HCV) screening still targets people at high
risk of infection. We aim to determine the cost-effectiveness of expanded HCV screening in …

Background The hepatitis C virus (HCV) care cascade has changed dramatically following
the introduction of direct‐acting anti‐virals (DAAs). Up‐to‐date estimates of the cascade are …